Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-L-Asparaginase Induction Regimen in Adult Acute Lymphoblastic Leukemia
NCT00002665Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jul 1995
- Primary completion
- Dec 2001
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of pegaspargase in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by SWOG Cancer Research Network. Primary endpoint: Response Rate. Started Jul 1995; status: completed.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00002665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002665.